EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of Carbonic Anhydrase Inhibition, Antioxidant Properties, and Selective Anticancer Activity of Methyl‐Substituted Halogenated and Methoxy Conduritols

Hayrani Eren Bostancı iD, Ebrar Büşra Yıldırım iD, Feyza Nur Çetin iD, Dilek Kaplan, Ümit Muhammet Koçyiğit iD, Alireza Poustforoosh iD, Burak Tüzün iD, Latif Kelebekli iD

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/5819417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 12.02.2026. Verfasst von Hayrani Eren Bostancı und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey, cumhuriyet.edu.tr. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Antioxidants, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to investigate the anticancer, potential antiepileptic agents, and antioxidant potentials of 10 methyl‐substituted halogenated and methoxy conduritols, which had been previously synthesized and characterized. The presence of active functional groups within their structures suggested their potential as bioactive molecules. Both in vitro and in silico approaches were employed to assess their biological activities and therapeutic relevance.

Methods

Anticancer activity was tested using the MCF‐7 breast cancer cell line and the L929 fibroblast cell line, with IC 50 values calculated to evaluate cytotoxicity. Antioxidant activity was determined using DPPH, FRAP, and TAS assays. The effects of methyl‐substituted mono‐ and dimethoxy halogenated conduritol derivatives (A and B forms) on the activities of carbonic anhydrase isoenzymes hCA I and hCA II were examined spectrophotometrically. Additionally, molecular docking studies were performed against hCA I (PDB ID: 3LXE), hCA II (PDB ID: 5AML), and breast cancer proteins (PDB ID: 1JNX, 1A52). ADME/T properties of the compounds were also evaluated to predict their pharmacokinetic and safety profiles.

Results

Among the synthesized derivatives, only compound 6 demonstrated notable anticancer activity, with an IC₅₀ of 20.22 μ M against MCF‐7 cells and moderate selectivity over healthy fibroblasts. The other compounds were largely inactive at the tested concentrations. Antioxidant assays demonstrated considerable free radical scavenging and reducing power. The synthesized conduritols showed strong inhibition of carbonic anhydrase isoenzymes, with Ki values ranging from 0.2083 ± 0.11 to 1.4944 ± 1.06 μ M for hCA I and 0.0857 ± 0.06 to 2.2098 ± 0.68 μ M for hCA II, outperforming standard inhibitors. Docking studies confirmed strong binding affinities to the investigated proteins, while ADME/T analysis suggested favorable pharmacokinetic properties.

Conclusions

The findings indicate that methyl‐substituted halogenated and methoxy conduritols possess anticancer, potential antiepileptic agents, and antioxidant potentials. Their strong carbonic anhydrase inhibitory activities highlight their promise as potential therapeutic agents for epilepsy and glaucoma. Overall, these compounds demonstrate considerable potential as multifunctional bioactive molecules and represent promising candidates for further preclinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsAntioxidantsAntineoplastic AgentsHumansMolecular Docking SimulationMCF-7 CellsAnimalsCarbonic AnhydrasesFemaleCarbonic Anhydrase ICarbonic Anhydrase IIMice

Stichwörter der Autor:innen

anticancerantiepilepticantioxidantenzyme inhibitionmolecular docking

Substanzen

Carbonic Anhydrase InhibitorsAntioxidantsAntineoplastic AgentsCarbonic AnhydrasesCarbonic Anhydrase ICarbonic Anhydrase II

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey, cumhuriyet.edu.tr.
  • Department of Chemistry, Faculty of Sciences and Arts, Ordu University, Ordu, Turkey, odu.edu.tr.
  • Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
  • Plant and Animal Production Department, Technical Sciences Vocational School of Sivas, Sivas Cumhuriyet University, Sivas, Turkey, cumhuriyet.edu.tr.

ORCID-Profile: Hayrani Eren Bostancı, Ebrar Büşra Yıldırım, Feyza Nur Çetin, Ümit Muhammet Koçyiğit, Alireza Poustforoosh, Burak Tüzün, Latif Kelebekli

Zitieren

APA

Bostancı, H. E., Yıldırım, E. B., Çetin, F. N., Kaplan, D., Koçyiğit, Ü. M., Poustforoosh, A., Tüzün, B., & Kelebekli, L. (2026). Investigation of Carbonic Anhydrase Inhibition, Antioxidant Properties, and Selective Anticancer Activity of Methyl‐Substituted Halogenated and Methoxy Conduritols. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/5819417

Vancouver

Bostancı HE, Yıldırım EB, Çetin FN, Kaplan D, Koçyiğit ÜM, Poustforoosh A, et al. Investigation of Carbonic Anhydrase Inhibition, Antioxidant Properties, and Selective Anticancer Activity of Methyl‐Substituted Halogenated and Methoxy Conduritols. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/5819417

BibTeX
@article{Bostanc2026,
  author = {Bostancı, Hayrani Eren and Yıldırım, Ebrar Büşra and Çetin, Feyza Nur and Kaplan, Dilek and Koçyiğit, Ümit Muhammet and Poustforoosh, Alireza and Tüzün, Burak and Kelebekli, Latif},
  title = {Investigation of Carbonic Anhydrase Inhibition, Antioxidant Properties, and Selective Anticancer Activity of Methyl‐Substituted Halogenated and Methoxy Conduritols},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/5819417}
}
Kostenlos starten →